Literature DB >> 20565257

Intracellular Casp8p41 content is inversely associated with CD4 T cell count.

Nathan W Cummins1, Wei Jiang, John McGinty, Gary D Bren, Ronald J Bosch, Alan Landay, Steven G Deeks, Jeffrey N Martin, Daniel Douek, Michael M Lederman, Jason Brenchley, Andrew D Badley.   

Abstract

Casp8p41 is a protein fragment generated by cleavage of procaspase 8 by human immunodeficiency virus (HIV) protease. We measured Casp8p41 content in memory CD4 T cells and analyzed the association of Casp8p41 content with CD4 T cell count, cross-sectionally and longitudinally. Casp8p41 content was inversely correlated with CD4 T cell count, and change in Casp8p41 content was associated with absolute CD4 T cell count with change over time. Casp8p41 change was a better predictor of CD4 T cell count change than activated CD8 T cell percentage or viral load and was comparable to bacterial 16s DNA levels. This suggests that Casp8p41 is a relevant mediator of CD4 T cell death during HIV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20565257      PMCID: PMC2906377          DOI: 10.1086/653705

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen.

Authors:  Alan L Landay; John Spritzler; Harold Kessler; Donna Mildvan; Minya Pu; Larry Fox; Dorothy O'Neil; Barbara Schock; Daniel Kuritzkes; Michael M Lederman
Journal:  J Infect Dis       Date:  2003-11-13       Impact factor: 5.226

2.  Apoptosis in HIV-infected individuals is an early marker occurring independently of high viremia.

Authors:  M Rothen; S Gratzl; H H Hirsch; C Moroni
Journal:  AIDS Res Hum Retroviruses       Date:  1997-06-10       Impact factor: 2.205

3.  Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.

Authors:  Benigno Rodríguez; Ajay K Sethi; Vinay K Cheruvu; Wilma Mackay; Ronald J Bosch; Mari Kitahata; Stephen L Boswell; W Christopher Mathews; David R Bangsberg; Jeffrey Martin; Christopher C Whalen; Scott Sieg; Suhrida Yadavalli; Steven G Deeks; Michael M Lederman
Journal:  JAMA       Date:  2006-09-27       Impact factor: 56.272

4.  Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo.

Authors:  Zilin Nie; Gary D Bren; Stacey R Vlahakis; Alicia Algeciras Schimnich; Jason M Brenchley; Sergey A Trushin; Sarah Warren; David J Schnepple; Colin M Kovacs; Mona R Loutfy; Daniel C Douek; Andrew D Badley
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

5.  Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease.

Authors:  L Meyaard; S A Otto; I P Keet; M T Roos; F Miedema
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

6.  Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression.

Authors:  F Pandolfi; M Pierdominici; A Oliva; G D'Offizi; I Mezzaroma; B Mollicone; A Giovannetti; L Rainaldi; I Quinti; F Aiuti
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-08-15

7.  Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.

Authors:  M L Gougeon; H Lecoeur; A Dulioust; M G Enouf; M Crouvoiser; C Goujard; T Debord; L Montagnier
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

8.  Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replication.

Authors:  Gary D Bren; Joe Whitman; Nathan Cummins; Brett Shepard; Stacey A Rizza; Sergey A Trushin; Andrew D Badley
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

9.  Analysis of HIV Protease Killing Through Caspase 8 Reveals a Novel Interaction Between Caspase 8 and Mitochondria.

Authors:  Alicia Algeciras-Schimnich; Anne-Sophie Belzacq-Casagrande; Gary D Bren; Zilin Nie; Julie A Taylor; Stacey A Rizza; Catherine Brenner; Andrew D Badley
Journal:  Open Virol J       Date:  2007-12-27

10.  HIV Protease Cleavage of Procaspase 8 is Necessary for Death of HIV-Infected Cells.

Authors:  Zilin Nie; Gary D Bren; Stacey A Rizza; Andrew D Badley
Journal:  Open Virol J       Date:  2008
View more
  11 in total

1.  The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak.

Authors:  Amy M Sainski; Sekar Natesampillai; Nathan W Cummins; Gary D Bren; Julie Taylor; Dyana T Saenz; Eric M Poeschla; Andrew D Badley
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

2.  Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition.

Authors:  Nathan W Cummins; Amy M Sainski-Nguyen; Sekar Natesampillai; Fatma Aboulnasr; Scott Kaufmann; Andrew D Badley
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

3.  Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size.

Authors:  Nathan W Cummins; Amy M Sainski; Haiming Dai; Sekar Natesampillai; Yuan-Ping Pang; Gary D Bren; Maria Cristina Miranda de Araujo Correia; Rahul Sampath; Stacey A Rizza; Daniel O'Brien; Joseph D Yao; Scott H Kaufmann; Andrew D Badley
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

4.  Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41.

Authors:  Nathan W Cummins; Jacqueline Neuhaus; Amy M Sainski; Michael A Strausbauch; Peter J Wettstein; Sharon R Lewin; Montserrat Plana; Stacey A Rizza; Zelalem Temesgen; Giota Touloumi; Matthew Freiberg; James Neaton; Andrew D Badley
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-14       Impact factor: 2.205

5.  Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells.

Authors:  Sekar Natesampillai; Zilin Nie; Nathan W Cummins; Dirk Jochmans; Gary D Bren; Jonathan B Angel; Andrew D Badley
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

Review 6.  Making sense of how HIV kills infected CD4 T cells: implications for HIV cure.

Authors:  Nathan W Cummins; Andrew D Badley
Journal:  Mol Cell Ther       Date:  2014-07-03

Review 7.  Casp8p41: The Protean Mediator of Death in CD4 T-cells that Replicate HIV.

Authors:  Rahul Sampath; Nathan W Cummins; Andrew D Badley
Journal:  J Cell Death       Date:  2016-09-27

8.  Increasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells.

Authors:  Rahul Sampath; Nathan W Cummins; Sekar Natesampillai; Gary D Bren; Thomas D Chung; Jason Baker; Keith Henry; Amélie Pagliuzza; Andrew D Badley
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

Review 9.  Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets.

Authors:  Zukile Mbita; Rodney Hull; Zodwa Dlamini
Journal:  Viruses       Date:  2014-08-19       Impact factor: 5.048

10.  Casp8p41 and HIV.

Authors:  Nathan W Cummins; Andrew D Badley
Journal:  Oncotarget       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.